Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    22383668 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated
Has Results
Study of Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Homozygous for the F508del-CFTR Mutation
Condition: Cystic Fibrosis
Interventions: Drug: Ivacaftor;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.